TGFβ signaling limits lineage plasticity in prostate cancer

Although treatment options for localized prostate cancer (CaP) are initially effective, the five-year survival for metastatic CaP is below 30%. Mutation or deletion of the PTEN tumor suppressor is a frequent event in metastatic CaP, and inactivation of the transforming growth factor (TGF) ß signalin...

Descripción completa

Detalles Bibliográficos
Autores principales: Hao, Yi, Bjerke, Glen A., Pietrzak, Karolina, Melhuish, Tiffany A., Han, Yu, Turner, Stephen D., Frierson, Henry F., Wotton, David
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5983872/
https://www.ncbi.nlm.nih.gov/pubmed/29782499
http://dx.doi.org/10.1371/journal.pgen.1007409

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5983872/
https://www.ncbi.nlm.nih.gov/pubmed/29782499
http://dx.doi.org/10.1371/journal.pgen.1007409

Ejemplares similares